BRIEF-Polyrizon Ltd Prices IPO Of 958,903 Units At $4.38 Per Unit-May 2024-www.financetom.com

BRIEF-Polyrizon Ltd Prices IPO Of 958,903 Units At $4.38 Per Unit

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Polyrizon Ltd Prices IPO Of 958,903 Units At $4.38 Per Unit

Nov 3, 2024 1:16 PM

Oct 28 (Reuters) - Polyrizon Ltd :

* POLYRIZON LTD - PRICES IPO OF 958,903 UNITS AT $4.38 PER

UNIT

Source text:

Further company coverage:

Previous page： Archer Aviation Strikes Air Taxi Deal in Japan, Shares Rise Next page： --Koppers Keeps Quarterly Dividend at $0.07 a Share, Payable Dec. 16 to Shareholders of Record Nov. 29

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Archer Aviation Strikes Air Taxi Deal in Japan, Shares Rise

Nov 9, 2024

11:31 AM EST, 11/07/2024 (MT Newswires) -- Archer Aviation ( ACHR ) and Soracle, a joint venture by Japan Airlines and Sumitomo, agreed to launch advanced air mobility services in Japan using Archer's Midnight aircraft, Archer said Thursday. Soracle aims to order up to 100 aircraft, valued at approximately $500 million, and establish urban air routes in cities like Tokyo...

--Koppers Keeps Quarterly Dividend at $0.07 a Share, Payable Dec. 16 to Shareholders of Record Nov. 29

Nov 9, 2024

11:33 AM EST, 11/07/2024 (MT Newswires) -- Price: 38.22, Change: -0.76, Percent Change: -1.95 ...

Mustang Bio Gets FDA Orphan Drug Designation for MB-108 in Malignant Glioma Treatment

Nov 9, 2024

11:34 AM EST, 11/07/2024 (MT Newswires) -- Mustang Bio ( MBIO ) said Thursday that MB-108, an oncolytic virus currently undergoing phase 1 clinical trial for malignant glioma treatment, has been granted orphan drug designation by the US Food and Drug Administration. The designation provides MB-108 seven years of market exclusivity in the US for the treatment. Mustang also said...

Canada Goose Beats Q2 Estimates, Company Warns Of 'Increased Pressure' On Luxury Consumer Spending

Nov 9, 2024

Canada Goose Holdings Inc. ( GOOS ) reported its second-quarter fiscal 2025 financial results before the market opened on Thursday. Here’s what you need to know. What To Know: Canada Goose reported second-quarter adjusted earnings per share of 5 cents, which may not compare to estimates for a loss of 4 cents. The company reported revenue of $267.8 million, beating...